Trials and Treatments: An Update on Pharmacotherapy for Idiopathic Pulmonary Fibrosis.

It is the most common cause of idiopathic interstitial pneumonias and was previously thought to be a rare disease, however, there is an increasing trend in incidence and prevalence rate globally [ 1 ].

also in 63,971 other papers

There was an observed trend toward improved FVC at week 12 in the valganciclovir treated group, however, as the numbers were small and the duration was short, a conclusion cannot be drawn regarding the effects on lung function, especially on a long-term basis.

also in 504 other papers